Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Geroldinger
Fumaric Acid Esters in Combination With a 6-Week Course of Narrowband Ultraviolet B Provides an Accelerated Response Compared With Fumaric Acid Esters Monotherapy in Patients With Moderate-To-Severe Plaque Psoriasis: A Randomized Prospective Clinical Stud
British Journal of Dermatology
Dermatology
Medicine
Related publications
Fumaric Acid Esters
Fumaric Acid Esters in the Management of Psoriasis
Psoriasis: Targets and Therapy
Dermatology
Rheumatology
Secukinumab Is Superior to Fumaric Acid Esters in Treating Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to Systemic Treatments: Results From the Randomized Controlled PRIME Trial
British Journal of Dermatology
Dermatology
Medicine
A 24‐week Multicentre, Randomised, Open‐label, Parallel‐group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate‐to‐severe Plaque Psoriasis Naïve to Systemic Treatment
British Journal of Dermatology
Dermatology
Medicine
Switch of Psoriasis Therapy From a Fumaric Acid Ester Mixture to Dimethyl Fumarate Monotherapy: Results of a Prospective Study
JDDG - Journal of the German Society of Dermatology
Dermatology
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Oronite Fumaric Acid!
Chemical and Engineering News
Chemical Engineering
New Polymorphisms Associated With Response to Anti-TNF Drugs in Patients With Moderate-To-Severe Plaque Psoriasis
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
